Boston Scientific (BSX) Total Liabilities (2009 - 2026)

Boston Scientific has disclosed Total Liabilities across 18 years of filings, most recently posting $20.0 billion for Q2 2026.

• In Q2 2026, Total Liabilities rose 6.02% year-over-year to $20.0 billion; the TTM figure through Jun 2026 stood at $20.0 billion (up 6.02% YoY), while the FY2025 annual figure was $19.2 billion, up 10.4% from the prior year.
• Total Liabilities came in at $20.0 billion for Q2 2026 at Boston Scientific, up from $18.2 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $20.0 billion in Q2 2026 to a low of $14.3 billion in Q3 2022.
• Average Total Liabilities over 5 years is $16.7 billion, with a median of $16.5 billion recorded in 2024.
• Year-over-year, Total Liabilities declined 7.19% in 2022 and grew 14.8% in 2024.
• Over 5 years, Total Liabilities stood at $14.9 billion in 2022, then gained by 4.77% to $15.6 billion in 2023, then increased by 11.44% to $17.4 billion in 2024, then advanced by 10.4% to $19.2 billion in 2025, then gained by 4.39% to $20.0 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $20.0 billion in Q2 2026, $18.2 billion in Q1 2026, and $19.2 billion in Q4 2025.